Search Results 1231-1240 of 16987 for Spectroscopy

  1. Focus areas - Psychiatric Genomics and Pharmacogenomics Program - Mayo Clinic Research

    The Psychiatric Genomics and Pharmacogenomics Program at Mayo Clinic studies links between genetics, bipolar disorder, addiction and alcohol use disorder to ...

  2. Breast cancer - Doctors and departments - Mayo Clinic

    Analyzing the genetic makeup of breast cancer cells to understand how DNA changes affect response to cancer treatments and personalize treatment options.

  3. Breast cancer - Doctors and departments - Mayo Clinic

    Learn about this common cancer, including information on prevention, symptoms, diagnosis and treatment.

  4. Publications - Xiaoning Ding, Ph.D. - Mayo Clinic

    GBD 2023 Asia Chronic Respiratory Disease Collaborators. Burden of chronic respiratory disease in Asia, 1990-2023: a systematic analysis for the Global ...

  5. Breast cancer - Doctors and departments - Mayo Clinic

    Analyzing the genetic makeup of breast cancer cells to understand how DNA changes affect response to cancer treatments and personalize treatment options.

  6. Gastroenterology and Hepatology - Clinical trials

    One uncontrolled, unpublished study suggests that a footstool improved bowel symptoms in nearly 98% of 153 constipated participants. The purpose of this study ...

  7. Breast cancer - Doctors and departments - Mayo Clinic

    Analyzing the genetic makeup of breast cancer cells to understand how DNA changes affect response to cancer treatments and personalize treatment options.

  8. Doctors and departments - Mayo Clinic

    Mayo Clinic doctors and researchers are studying new ways to care for people with germ cell tumors. Cancer research is conducted in coordination with the Mayo ...

  9. Molecular breast imaging - Doctors & Departments - Mayo Clinic

    Learn about this breast cancer screening test that's sometimes used in addition to mammograms, especially for those with dense breast tissue.

  10. Clinical trials - Oncology (Medical)

    All study subjects will receive acalabrutinib, durvalumab, and venetoclax. Acalabrutinib is FDA approved for treatment of chronic lymphocytic leukemia and small ...